Why the study?
Arterial hypertension and diabetes mellitus are worsening globally, alongside a growing digital health market of mobile applications intended to aid chronic disease management.
Do mobile health applications improve biochemical parameters and clinical efficacy in adults and elderly with hypertension and/or diabetes mellitus compared to usual care?
Population
Adult and elderly population treated for arterial hypertension and/or diabetes mellitus in 26 studies
Comparison
Mobile health applications vs usual care
Design
Systematic review and meta-analysis of randomized and cohort clinical trials
Authors
Loading...
May support mobile app integration into diabetes care; confirms HbA1c reduction versus usual care in meta-analysis.
Do mobile health applications improve biochemical parameters and clinical efficacy in adults and elderly with hypertension and/or diabetes mellitus compared to usual care?
The use of mobile health applications for monitoring diabetes and hypertension significantly reduces glycated hemoglobin levels compared to usual care.
Ferreira et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: